UPDATED Sep 05, 2025
Discover large cap Norwegian Pharmaceuticals & Biotech companies that are on the OSEAX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
PHO | NOK 61.70 | 0.3% | 22.4% | NOK 1.6b | NOK 82.50 | PS3.1x | E120.4% | 0% | ||
AZT | NOK 27.20 | -4.2% | 51.1% | NOK 1.4b | NOK 29.00 | PE495.6x | E79.5% | n/a | ||
TRMED | NOK 3.60 | 12.5% | 245.5% | NOK 1.3b | n/a | PS12707.5x | n/a | n/a | ||
VISTN | NOK 23.30 | -2.1% | -2.9% | NOK 1.0b | n/a | PE13.6x | n/a | 5.4% | ||
HBC | NOK 1.75 | -6.2% | -12.5% | NOK 719.4m | n/a | PS2.7x | n/a | n/a | ||
LYTIX | NOK 7.74 | -3.0% | -12.4% | NOK 528.3m | NOK 13.00 | PS869x | S205.0% | n/a | ||
NYKD | NOK 1.54 | 0.1% | -70.2% | NOK 503.5m | NOK 8.50 | PS6.3x | E-7.2% | 62.4% | ||
NORD | NOK 81.00 | 0% | n/a | NOK 415.7m | n/a | PE3.3x | n/a | 0% | ||
NAVA | NOK 21.60 | -0.5% | -22.0% | NOK 381.5m | NOK 36.00 | PB1.8x | E108.2% | n/a | ||
ZLNA | NOK 13.33 | -7.4% | n/a | NOK 272.7m | n/a | PS5144.4x | E-26.3% | n/a | ||
SOFTX | NOK 0.12 | 5.5% | 346.2% | NOK 261.6m | n/a | PS28.1x | n/a | n/a | ||
EXTX | NOK 2.48 | 8.8% | -53.6% | NOK 156.9m | n/a | PB1.4x | n/a | n/a | ||
ONCIN | NOK 1.50 | 7.3% | n/a | NOK 146.6m | n/a | PS7.3x | n/a | n/a | ||
ABS | NOK 3.97 | 3.4% | -70.8% | NOK 106.6m | n/a | PS2.3x | E126.9% | n/a | ||
CRNA | NOK 0.61 | -1.0% | -45.7% | NOK 63.9m | n/a | PE-9.7x | n/a | n/a | ||
BGBIO | NOK 1.18 | -1.8% | -87.6% | NOK 46.0m | n/a | PS8.5x | E-55.7% | n/a | ||
PCIB | NOK 0.40 | 0% | -78.4% | NOK 14.9m | n/a | PS2.2x | n/a | n/a |